dc.contributor.author | Ho-Yen, C | en_US |
dc.contributor.author | Bowen, RL | en_US |
dc.contributor.author | Kermorgant, S | en_US |
dc.contributor.author | Jones, JL | en_US |
dc.date.accessioned | 2016-10-20T11:59:16Z | |
dc.date.issued | 2013-05-28 | en_US |
dc.date.submitted | 2016-08-03T12:06:15.031Z | |
dc.identifier.issn | 0007-0920 | en_US |
dc.identifier.other | 10.1038/bjc.2013.249 | |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/15971 | |
dc.format.extent | 2195 - 2196 | en_US |
dc.language.iso | en | en_US |
dc.relation.ispartof | BRITISH JOURNAL OF CANCER | en_US |
dc.rights | Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License | |
dc.title | Comment on 'High MET expression is an adverse prognostic factor in patients with triple-negative breast cancer' | en_US |
dc.type | Article | |
dc.rights.holder | & 2013 Cancer Research UK. | |
dc.identifier.doi | 10.1038/bjc.2013.249 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000319561300040&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 10 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 108 | en_US |